Clinical Trial Update: Study of Histrelin Subdermal Implant in Patients With Prostate Cancer [Phase 3]

View source ↗

Summary

Phase 3 clinical trial investigating the histrelin subdermal implant in patients with prostate cancer has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenocarcinoma of the Prostate
• Prostate Cancer

Drugs mentioned

• Histrelin subdermal implant (histrelin)

Snippet

Sponsor: Endo Pharmaceuticals | Conditions: Prostate Cancer, Adenocarcinoma of the Prostate | Phase 3 | Status: COMPLETED